Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Ionis Pharmaceuticals, (ISIS)

Ionis Pharmaceuticals,
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ISIS
DateTimeSourceHeadlineSymbolCompany
06/01/201012:00PR Newswire (US)Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceLSE:ISIS
05/01/201013:00PR Newswire (US)Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001LSE:ISIS
21/12/200913:15PR Newswire (US)Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to TevaLSE:ISIS
23/11/200913:00PR Newswire (US)Isis Pharmaceuticals (Nasdaq: ISIS) Letter to ShareholdersLSE:ISIS
20/10/200912:00PR Newswire (US)Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceLSE:ISIS
09/09/200912:00PR Newswire (US)Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged ConferenceLSE:ISIS
06/08/200913:23Dow Jones NewsIsis 2Q Loss Narrows, Helped By Genzyme PartnershipLSE:ISISIsis Pharmaceuticals Inc.
06/08/200912:00PR Newswire (US)Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009LSE:ISIS
04/08/200912:00PR Newswire (US)Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ConferenceLSE:ISIS
20/05/200918:45Dow Jones NewsUPDATE: Genzyme, Isis Cholesterol Drug Data Raise QuestionsLSE:ISISIsis Pharmaceuticals Inc.
20/05/200915:06Dow Jones NewsGenzyme, Isis Cholesterol Drug Meets Goal In Late StudyLSE:ISISIsis Pharmaceuticals Inc.
07/05/200912:54Dow Jones NewsIsis Swings To 1Q Profit Amid Gain, Partnership RevenueLSE:ISISIsis Pharmaceuticals Inc.
14/02/200613:00PR Newswire (US)OncoGenex Appoints New CFO and Board MemberLSE:ISIS
16/08/200514:18PR Newswire (US)OncoGenex Announces Completion of $12.8 Million Venture FinancingLSE:ISIS
 Showing the most relevant articles for your search:NASDAQ:ISIS

Your Recent History

Delayed Upgrade Clock